These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

503 related articles for article (PubMed ID: 35692393)

  • 1. Emerging Role of Epitranscriptomics in Diabetes Mellitus and Its Complications.
    Geng X; Li Z; Yang Y
    Front Endocrinol (Lausanne); 2022; 13():907060. PubMed ID: 35692393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of m
    Benak D; Benakova S; Plecita-Hlavata L; Hlavackova M
    Front Endocrinol (Lausanne); 2023; 14():1223583. PubMed ID: 37484960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The rise of epitranscriptomics: recent developments and future directions.
    Cerneckis J; Ming GL; Song H; He C; Shi Y
    Trends Pharmacol Sci; 2024 Jan; 45(1):24-38. PubMed ID: 38103979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring epitranscriptomics for crop improvement and environmental stress tolerance.
    Yang X; Patil S; Joshi S; Jamla M; Kumar V
    Plant Physiol Biochem; 2022 Jul; 183():56-71. PubMed ID: 35567875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Shaping the Bacterial Epitranscriptome-5'-Terminal and Internal RNA Modifications.
    Schauerte M; Pozhydaieva N; Höfer K
    Adv Biol (Weinh); 2021 Aug; 5(8):e2100834. PubMed ID: 34121369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epitranscriptome sequencing technologies: decoding RNA modifications.
    Li X; Xiong X; Yi C
    Nat Methods; 2016 Dec; 14(1):23-31. PubMed ID: 28032622
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RNA Modifications and Epigenetics in Modulation of Lung Cancer and Pulmonary Diseases.
    Teng PC; Liang Y; Yarmishyn AA; Hsiao YJ; Lin TY; Lin TW; Teng YC; Yang YP; Wang ML; Chien CS; Luo YH; Chen YM; Hsu PK; Chiou SH; Chien Y
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epitranscriptomics in metabolic disease.
    Matsumura Y; Wei FY; Sakai J
    Nat Metab; 2023 Mar; 5(3):370-384. PubMed ID: 36959512
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic Regulation Associated With Sirtuin 1 in Complications of Diabetes Mellitus.
    Wang A J; Wang S; Wang B J; Xiao M; Guo Y; Tang Y; Zhang J; Gu J
    Front Endocrinol (Lausanne); 2020; 11():598012. PubMed ID: 33537003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic Modifications and Non-Coding RNA in Diabetes-Mellitus-Induced Coronary Artery Disease: Pathophysiological Link and New Therapeutic Frontiers.
    Prandi FR; Lecis D; Illuminato F; Milite M; Celotto R; Lerakis S; Romeo F; Barillà F
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Regulation of RNA Modification Systems: The Next Frontier in Epitranscriptomics?
    Schaefer MR
    Genes (Basel); 2021 Feb; 12(3):. PubMed ID: 33652758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deciphering the Epitranscriptomic Signatures in Cell Fate Determination and Development.
    Haran V; Lenka N
    Stem Cell Rev Rep; 2019 Aug; 15(4):474-496. PubMed ID: 31123982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systematic calibration of epitranscriptomic maps using a synthetic modification-free RNA library.
    Zhang Z; Chen T; Chen HX; Xie YY; Chen LQ; Zhao YL; Liu BD; Jin L; Zhang W; Liu C; Ma DZ; Chai GS; Zhang Y; Zhao WS; Ng WH; Chen J; Jia G; Yang J; Luo GZ
    Nat Methods; 2021 Oct; 18(10):1213-1222. PubMed ID: 34594034
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic changes underlie the association between diabetes mellitus and oral diseases.
    Veysari SK; Asghari M; Farshad F; Hodjat M
    Mol Biol Rep; 2023 Aug; 50(8):6987-6996. PubMed ID: 37378745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting epigenetics in diabetic cardiomyopathy: Therapeutic potential of flavonoids.
    Zhou Y; Suo W; Zhang X; Yang Y; Zhao W; Li H; Ni Q
    Biomed Pharmacother; 2023 Jan; 157():114025. PubMed ID: 36399824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epitranscriptome in Ischemic Cardiovascular Disease: Potential Target for Therapies.
    Quiles-Jiménez A; Dahl TB; Bjørås M; Alseth I; Halvorsen B; Gregersen I
    Stroke; 2022 Jun; 53(6):2114-2122. PubMed ID: 35240858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential role of m6A RNA methylation in diabetic retinopathy.
    Kumari N; Karmakar A; Ahamad Khan MM; Ganesan SK
    Exp Eye Res; 2021 Jul; 208():108616. PubMed ID: 33979630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The m
    Livneh I; Moshitch-Moshkovitz S; Amariglio N; Rechavi G; Dominissini D
    Nat Rev Neurosci; 2020 Jan; 21(1):36-51. PubMed ID: 31804615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Census and Categorization Method of Epitranscriptomic Marks.
    Mathlin J; Le Pera L; Colombo T
    Int J Mol Sci; 2020 Jun; 21(13):. PubMed ID: 32630140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. miRNA signatures in diabetic retinopathy and nephropathy: delineating underlying mechanisms.
    Kaur P; Kotru S; Singh S; Munshi A
    J Physiol Biochem; 2022 Feb; 78(1):19-37. PubMed ID: 35098434
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.